corpus albicans

(redirected from albicans)
Also found in: Thesaurus, Medical, Encyclopedia.
Related to albicans: candida

corpus al·bi·cans

 (ăl′bĭ-kănz′)
n.
The white fibrous scar tissue in an ovary that results after the involution and regression of the corpus luteum.

[New Latin corpus albicāns : Latin corpus, body + New Latin albicāns, whitening.]
References in periodicals archive ?
albicans most commonly cause bloodstream infections, but increased incidence of bloodstream infections by other C.
Candida albicans is an opportunistic fungus (a form of yeast) that normally lives on the human body without causing any harm.
To treat Candida albicans, a common fungus/yeast that can cause illness in those with weakened immune systems, researchers limited the fungus' access to iron, an element crucial to the organism's survival.
Candidiasis is a fungal infection caused by Candida species and Candida albicans (C.
Candida albicans appears to be the cause for 80 to 92 percent of vulvovaginal candidiasis (6).
Strains: Candida albicans (ATCC 14053 and 64546) and Candida krusei (ATCC 6258) strains were used as a reference and eight different clinical isolates of Candida spp were evaluated in this study.
From the total tree species selected by cows, young and mature leaves of Neomillspaughia emargiata, Tabernaemontana amygdalifolia, Piscidia piscipula, Gymnopodium floribundum, Havardia albicans, Lonchocarpus rugosus, Guazuma ulmifolia, Lysiloma latisiliquum, Luecaena leucocephala, Pithecellobium albicans, Haematoxylum campechianum, Mimosa bahamensis, Bursera simaruba, Caesalpinia gaumeri, Helicteres barvensis, Machaonia lindeniana, Vitex gaumeri, and Bauhinia divaricata were selected due to their highest consumption by animals.
[1] Compared to other medically important fungi, Candida albicans remains the most persistent and pervasive yeast pathogen in humans, capable of invading virtually every tissue of the body.
Candida albicans) (13) o el incremento de especies con resistencia natural o disminuida (p.
The most challenging clinical problem is the increased rate of non-Candida albicans isolation and the rapidly growing resistance of Candida species [3].
Similarly, among fungal infections, due to its opportunistic nature, Candida albicans is one of the major fungal pathogens that has emerged in the immunocompromised conditions such as AIDS, diabetes, organ transplantation, burn [3, 4], and coinfection with organisms such as MTB [2].
In the United States and Europe, VVC is predominantly caused by Candida albicans (~76-89%) although non-albicans Candida species comprise larger proportions in other geographical regions [4].